For comments, suggestions
Created with Raphaël 2.1.0 10.02.2017 Filing date 12.09.2018 Validation fee payment 31.01.2019 (A1) Patent application published 11.09.2023 AGEPI application filing date 30.11.2023 (T2) Translation of the validated European patent 23.05.2025 10.02.2026 Valid until 11.02.2027 Renewal fee to be paid until 10.02.2037 Patent will expire on

Patent in force


(210)Number of the EPO application17706102
(220)Filing date of the EPO application2017.02.10
(80)EPO patent specification publication (B)EPB nr. 24/2023, 2023.06.14
(110)EPO patent number3413897
(11)Number of the documentMD 3413897 T2
(21)Number of the applicatione 2018 1208
(71)Name(s) of applicant(s), code of the countryMERCK SHARP & DOHME LLC, US;
(72)Name(s) of inventor(s), code of the countryHAZUDA Daria, US;
MILLER Michael D., US;
GROBLER Jay A., US;
NICOLL-GRIFFITH Deborah Anne, CA;
(73)Name(s) of owner(s), code of the countryMERCK SHARP & DOHME LLC, US;
(54)Title of the inventionMethods for treatment and prophylaxis of HIV and AIDS
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/7076 (2006.01.01); A61P 31/18 (2006.01.01); A61P 37/02 (2006.01.01); C07H 19/173 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2019.01.31
(49)Date of publication of the translation of the validated European patent specification2023.11.30
(30)Priority201662294576 P, 2016.02.12, US; 201662297657 P, 2016.02.19, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2017/017283, 2017.02.10
(87)International publicationWO 2017/139519, 2017.08.17
Up
/Inventions/details/3413897